<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pirozzi CS</submitter><funding>NIEHS NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>Foundation for the National Institutes of Health</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pagination>223</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6245799</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The identification of smoking-related lung disease in current and former smokers with normal FEV&lt;sub>1&lt;/sub> is complex, leading to debate regarding using a ratio of forced expiratory volume in 1 s to forced vital capacity (FEV&lt;sub>1&lt;/sub>/FVC) of less than 0.70 versus the predicted lower limit of normal (LLN) for diagnosis of airflow obstruction. We hypothesized that the discordant group of ever-smokers with FEV&lt;sub>1&lt;/sub>/FVC between the LLN and 0.70 is heterogeneous, and aimed to characterize the burden of smoking-related lung disease in this group.&lt;h4>Methods&lt;/h4>We compared spirometry, chest CT characteristics, and symptoms between 161 ever-smokers in the discordant group and 940 ever-smokers and 190 never-smokers with normal FEV&lt;sub>1&lt;/sub> and FEV&lt;sub>1&lt;/sub>/FVC</pubmed_abstract><journal>Respiratory research</journal><pubmed_title>Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.</pubmed_title><pmcid>PMC6245799</pmcid><funding_grant_id>P30 ES005605</funding_grant_id><funding_grant_id>U01 HL137880</funding_grant_id><funding_grant_id>HHSN268200900015C</funding_grant_id><funding_grant_id>HHSN268200900016C</funding_grant_id><funding_grant_id>HHSN268200900017C</funding_grant_id><funding_grant_id>HHSN268200900019C</funding_grant_id><funding_grant_id>U01 HL128952</funding_grant_id><funding_grant_id>R01 HL122438</funding_grant_id><funding_grant_id>K24 HL138188</funding_grant_id><funding_grant_id>HHSN268200900020C</funding_grant_id><funding_grant_id>K23 HL130627</funding_grant_id><funding_grant_id>HHSN268200900013C</funding_grant_id><funding_grant_id>HHSN268200900014C</funding_grant_id><funding_grant_id>K24 HL137013</funding_grant_id><funding_grant_id>HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C HHSN268200900019C, HHSN268200900020C</funding_grant_id><funding_grant_id>P30 ES006694</funding_grant_id><pubmed_authors>Krishnan JA</pubmed_authors><pubmed_authors>Murray S</pubmed_authors><pubmed_authors>Han MLK</pubmed_authors><pubmed_authors>Hansel NN</pubmed_authors><pubmed_authors>Anderson WH</pubmed_authors><pubmed_authors>Kleerup EC</pubmed_authors><pubmed_authors>Oelsner EC</pubmed_authors><pubmed_authors>Bowler RP</pubmed_authors><pubmed_authors>Putcha N</pubmed_authors><pubmed_authors>Alexis NE</pubmed_authors><pubmed_authors>Christenson SA</pubmed_authors><pubmed_authors>Comellas AP</pubmed_authors><pubmed_authors>Carretta EE</pubmed_authors><pubmed_authors>Graham Barr R</pubmed_authors><pubmed_authors>Doerschuk CM</pubmed_authors><pubmed_authors>Cooper CB</pubmed_authors><pubmed_authors>Newell JD</pubmed_authors><pubmed_authors>Lazarus SC</pubmed_authors><pubmed_authors>Woodruff PG</pubmed_authors><pubmed_authors>Couper DJ</pubmed_authors><pubmed_authors>Freeman CM</pubmed_authors><pubmed_authors>Tashkin DP</pubmed_authors><pubmed_authors>Michael Wells J</pubmed_authors><pubmed_authors>Quibrera PM</pubmed_authors><pubmed_authors>Scholand MB</pubmed_authors><pubmed_authors>O'Neal WK</pubmed_authors><pubmed_authors>Han MK</pubmed_authors><pubmed_authors>Croxton T</pubmed_authors><pubmed_authors>Postow L</pubmed_authors><pubmed_authors>Paine R</pubmed_authors><pubmed_authors>Kanner RE</pubmed_authors><pubmed_authors>Criner GJ</pubmed_authors><pubmed_authors>Hoffman EA</pubmed_authors><pubmed_authors>LaVange LM</pubmed_authors><pubmed_authors>NHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS)</pubmed_authors><pubmed_authors>Hastie AT</pubmed_authors><pubmed_authors>Martinez FJ</pubmed_authors><pubmed_authors>Boucher RC</pubmed_authors><pubmed_authors>Gu T</pubmed_authors><pubmed_authors>Curtis JL</pubmed_authors><pubmed_authors>Bleecker ER</pubmed_authors><pubmed_authors>Wise RA</pubmed_authors><pubmed_authors>Pirozzi CS</pubmed_authors><pubmed_authors>Ortega VE</pubmed_authors><pubmed_authors>Meyers DA</pubmed_authors><pubmed_authors>Barjaktarevic I</pubmed_authors><pubmed_authors>Crystal RG</pubmed_authors><pubmed_authors>Dransfield MT</pubmed_authors><pubmed_authors>Rennard SI</pubmed_authors><pubmed_authors>Kaner RJ</pubmed_authors><pubmed_authors>Martinez CH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.</name><description>&lt;h4>Background&lt;/h4>The identification of smoking-related lung disease in current and former smokers with normal FEV&lt;sub>1&lt;/sub> is complex, leading to debate regarding using a ratio of forced expiratory volume in 1 s to forced vital capacity (FEV&lt;sub>1&lt;/sub>/FVC) of less than 0.70 versus the predicted lower limit of normal (LLN) for diagnosis of airflow obstruction. We hypothesized that the discordant group of ever-smokers with FEV&lt;sub>1&lt;/sub>/FVC between the LLN and 0.70 is heterogeneous, and aimed to characterize the burden of smoking-related lung disease in this group.&lt;h4>Methods&lt;/h4>We compared spirometry, chest CT characteristics, and symptoms between 161 ever-smokers in the discordant group and 940 ever-smokers and 190 never-smokers with normal FEV&lt;sub>1&lt;/sub> and FEV&lt;sub>1&lt;/sub>/FVC</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Nov</publication><modification>2026-05-05T22:51:52.469Z</modification><creation>2019-03-27T00:08:58Z</creation></dates><accession>S-EPMC6245799</accession><cross_references><pubmed>30454050</pubmed><doi>10.1186/s12931-018-0911-z</doi></cross_references></HashMap>